Some major asthma inhaler manufacturers announced $35 a month caps on out-of-pocket costs. The price cap will apply to people with commercial/private insurance (through your job or federal or state marketplace) or no insurance. If you have government-funded insurance (such as Medicare, Medicaid, or Tricare), you won’t qualify for a price cap, but you may qualify for a patient assistance program that can reduce what you pay. The inhalers that will be price capped include: AstraZeneca…
Quelle: Asthma and Allergy Foundation of America
Artikel: What You Need to Know About the $35 Price Cap on Asthma Inhalers
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- Wildfire Relief Efforts for Los Angeles Region
- AAFA Releases 2025 State Honor Roll™ Report
- Wildfires and How They Affect Air Quality and Asthma
- What You Need to Know About the $35 Price Cap on Asthma Inhalers
- AAFA’s Major Achievements in 2024
- Understanding Mild to Moderate Asthma (Video)
- December Research Update: Impact of Changing Inhaler Market on Asthma, Air Pollution, and Solar Urticaria
- Gifts to Give People with Asthma and Allergies
- How Can You Tell the Difference Between COVID-19, a Cold, the Flu, RSV, Allergies, and Asthma?
- Coronavirus (COVID-19): What People With Asthma Need to Know
